A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): Effects on symptoms, colonic transit and quality of life

International Journal of Colorectal Disease

Volumn 28, Issue 3, 2013, Pages 349-358

  Cappello, Carmelina ^a   Tremolaterra, Fabrizio ^b   Pascariello, Annalisa ^a   Ciacci, Carolina ^c   Iovino, Paola ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Bloating; Flatulence; Irritable bowel syndrome; Prebiotic; Probiotic; Randomised clinical trial; Symbiotic

Indexed keywords

PLACEBO; PREBIOTIC AGENT; PROBINUL; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLOATING; BRISTOL SCALE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEFECATION URGENCY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FEMALE; FLATULENCE; HUMAN; INSTRUMENT VALIDATION; INTESTINE FLORA; INTESTINE TRANSIT TIME; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SENSE OF INCOMPLETE EVACUATION; SHORT FORM 36; SYMPTOM; VISUAL ANALOG SCALE;

ABDOMINAL PAIN; ADULT; DEMOGRAPHY; DIET; FEMALE; FLATULENCE; GASTROINTESTINAL TRANSIT; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MEDICATION ADHERENCE; PAIN MEASUREMENT; PROBIOTICS; QUALITY OF LIFE; SYMBIOSIS;

EID: 84879460966     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1552-1     Document Type: Article

References (36)

1. Thompson WG, Longstreth GF, Drossman DA et al (1999) Functional bowel disorders and functional abdominal pain. Gut 45(Suppl 2):II43-II47
2. American college of Gastroenterology IBS task force (2009) An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenter 104:S1-S35
3. Gibson GR, Probert HM, Van Loo J et al (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17:259-275
4. Schrezenmeir J, De Vrese M (2001) Probiotics, probiotic, and symbiotic - approaching a definifion. Am J Clin Nutr 73:361S-364S
5. Whorwell PJ, Altringer L, Morel J et al (2006) Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101:1581-1590 (Pubitemid 43980633)
6. Kim HJ, Camilleri M, McKinzie S et al (2003) A randomized controlled trial of prebiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17:895-904 (Pubitemid 36459602)
7. Kim HJ, Vazquez Roque MI, Camilleri M et al (2005) A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 17:687-696 (Pubitemid 41400717)
8. Ringel-Kulka T, Palsson OS, Maier D et al (2011) Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol 45(6):518-525
9. Spiller R (2008) Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 28(4):385-396 (Pubitemid 352033280)
10. Brenner DM, Moeller MJ, Chey WD et al (2009) The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 104:1033-1049
11. Moayyedi P, Ford AC, Talley NJ et al (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59(3):325-332
12. Spiller R, Campbell E (2006) Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol 22(1):13-17 (Pubitemid 44124277)
13. Lee BJ, Bak YT (2011) Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil 17(3):252-266
14. Amaral FA, Sachs D, Costa VV et al (2008) Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A 105:2193-2197 (Pubitemid 351439487)
15. Andriulli A, Neri M, Loguercio C et al (2008) Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. J Clin Gastroenterol 42(Suppl 3 Pt 2):S218-S223
16. Longstreth GF, Thompson WG, Chey WD et al (2006) Functional bowel disorders. Gastroenterology 130:1480-1491
17. Drossman DA, Zhiming LI, Toner BB et al (1995) Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci 40:986-995
18. Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920-924 (Pubitemid 27382038)
19. Heaton KW, Radvan J, Cripps H et al (1992) Defecation frequency and timing, and stool form in general population: a prospective study. Gut 33:818-824
20. Heaton KW, O'Donnell LJ (1994) An office guide to whole-gut transit time. Patients' recollection of their stool form. J Clin Gastroenterol 19:28-30 (Pubitemid 24222236)
21. Heaton KW, Ghosh S, Braddon FE (1991) How bad are the symptoms and bowel dysfunction of patients with irritable bowel syndrome? A prospective controlled study with emphasis on stool form. Gut 32:73-79
22. Metcalf AM, Phillips SF, Zinsmeister AR et al (1987) Simplified assessment of segmental colonic transit. Gastroenterology 92:40-47 (Pubitemid 17207659)
23. Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025-1036 (Pubitemid 28527158)
24. Gawrońska A, Dziechciarz P, Horvath A, Szajewska H (2007) A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 25(2):177-184 (Pubitemid 46046374)
25. Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R (2005) A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 22(5):387-394 (Pubitemid 41248105)
26. Ringel Y, Williams RE, Kalilani L et al (2009) The prevalence, characteristics and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 7:68-72
27. Parkes GC, Sanderson JD, Whelan K (2010) Treating irritable bowel syndrome with probiotics: the evidence. Proc Nutr Soc 69:187-194
28. Chang JY, Talley NJ (2010) Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci 31:326-334
29. Whitehead WE, Palsson OS, Levy RL et al (2006) Reports of 'satisfactory relief' by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Am J Gastroenterol 101(5):1057-1065 (Pubitemid 43725320)
30. Ng SC, Hart AL, Kamm MA et al (2009) Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 15:300-310
31. Forsythe P, Bienenstock J (2010) Immunomodulation by commensal and probiotic bacteria. Immunol Invest 39:429-448
32. Ohland CL, Macnaughton WK (2010) Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 298:G807-G819
33. Preidis GA, Versalovic J (2009) Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136:2015-2031
34. Paineau D, Payen F, Panserieu S et al (2008) The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. Br J Nutr 99(2):311-318
35. Cattivelli D, Soldi S, Elli M, et al. (2005) Assessing a multi strain symbiotic dietary supplement. 3rd Probiotics, Prebiotics and New Foods 4-6 Sep 2005, Urbaniana University, Rome
36. Tsuchiya J, Barreto R, Okura R et al (2004) Single blind follow up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin J Dig Dis 5:169-174 (Pubitemid 40028569)